Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2021
New Titles 2020
Price and Ordering Information
Subscription Rates 2021
Subscription Rates 2020
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2020
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Journal Catalog 2020
Journal Catalog 2021
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.912
5 Year Impact Factor:
2.947
Subscribe to this Journal
Book Proposal
Become an Executive Guest Editor
New Journal Proposal
Become a Section Editor
Become a Reviewer
Join Editorial Board
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 9
- Number 6
Molecular Features, Markers, Drug Targets, and Prospective Targeted Therapeutics in Cardiac Myxoma
,
9
(
6
):
705
- 716
Debmalya Barh, Anil Kumar, Suvro Chatterjee and Triantafillos Liloglou
DOI:
10.2174/156800909789271549
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?
,
9
(
6
):
717
- 728
C. Constantinou, K. A. Papas and A. I. Constantinou
DOI:
10.2174/156800909789271512
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma
,
9
(
6
):
729
- 737
S. Fulda
DOI:
10.2174/156800909789271521
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma
,
9
(
6
):
738
- 747
H. Huynh, V. C. Ngo, S. P. Choo, D. Poon, H. N. Koong, C. H. Thng, H. C. Toh, L. Zheng, L. C. Ong, Y. Jin, I. C. Song, A. P.C. Chang, H. S. Ong, A. Y.F. Chung, P. K.H. Chow and K. C. Soo
DOI:
10.2174/156800909789271530
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
,
9
(
6
):
748
- 760
J. van der Veeken, S. Oliveira, R. M. Schiffelers, G. Storm, P.M.P. van Bergen en Henegouwen and R. C. Roovers
DOI:
10.2174/156800909789271495
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia
,
9
(
6
):
761
- 776
H. Reikvam, E. Ersvær and O. Bruserud
DOI:
10.2174/156800909789271486
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)
,
9
(
6
):
777
- 788
J. C. Doloff, N. Khan, J. Ma, E. Demidenko, H. M. Swartz and Y. Jounaidi
DOI:
10.2174/156800909789271503
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board
COPE Compliant
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Increase Visibility of your Article
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Editor's Choice
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2020
⇨ Journal Catalog 2021
⇨ Most Accessed Articles
⇨ Most Cited Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Newsletter
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics:
5.2
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2021 Bentham Science
|
Privacy Policy